Considering our results indicated suppression of B cell-mediated immunity, leukocyte-mediated immunity, and complement activation, in addition to these mechanisms, may suggest that APP helps tumor cells evade immune detection by downregulating both adaptive and innate immune responses, including macrophages, B cells, and microglia. The gene discussed is APP; the disease is neoplasm.